JPH0428718B2 - - Google Patents

Info

Publication number
JPH0428718B2
JPH0428718B2 JP2040884A JP4088490A JPH0428718B2 JP H0428718 B2 JPH0428718 B2 JP H0428718B2 JP 2040884 A JP2040884 A JP 2040884A JP 4088490 A JP4088490 A JP 4088490A JP H0428718 B2 JPH0428718 B2 JP H0428718B2
Authority
JP
Japan
Prior art keywords
cea
antibody
labeled
antibodies
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP2040884A
Other languages
English (en)
Japanese (ja)
Other versions
JPH02238000A (ja
Inventor
Yukio Ochi
Tadayoshi Myazaki
Yoshihiro Kajita
Takashi Yatani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BAKUSUTAA DAIAGUNOSUCHITSUKUSU Inc
Original Assignee
BAKUSUTAA DAIAGUNOSUCHITSUKUSU Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BAKUSUTAA DAIAGUNOSUCHITSUKUSU Inc filed Critical BAKUSUTAA DAIAGUNOSUCHITSUKUSU Inc
Publication of JPH02238000A publication Critical patent/JPH02238000A/ja
Publication of JPH0428718B2 publication Critical patent/JPH0428718B2/ja
Granted legal-status Critical Current

Links

Classifications

    • G01N33/57565—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/804—Radioisotope, e.g. radioimmunoassay
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/81—Carrier - bound or immobilized peptides or proteins and the preparation thereof, e.g. biological cell or cell fragment as carrier
    • Y10S530/812—Peptides or proteins is immobilized on, or in, an organic carrier
    • Y10S530/815—Carrier is a synthetic polymer
    • Y10S530/816—Attached to the carrier via a bridging agent
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/828—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
JP2040884A 1981-06-02 1990-02-20 がん胎児性抗原の精製法 Granted JPH02238000A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/269,217 US4489167A (en) 1981-06-02 1981-06-02 Methods and compositions for cancer detection
US269217 1981-06-02

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP57095572A Division JPS58758A (ja) 1981-06-02 1982-06-02 がん胎児性抗原の定量方法

Publications (2)

Publication Number Publication Date
JPH02238000A JPH02238000A (ja) 1990-09-20
JPH0428718B2 true JPH0428718B2 (en:Method) 1992-05-15

Family

ID=23026305

Family Applications (2)

Application Number Title Priority Date Filing Date
JP57095572A Granted JPS58758A (ja) 1981-06-02 1982-06-02 がん胎児性抗原の定量方法
JP2040884A Granted JPH02238000A (ja) 1981-06-02 1990-02-20 がん胎児性抗原の精製法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP57095572A Granted JPS58758A (ja) 1981-06-02 1982-06-02 がん胎児性抗原の定量方法

Country Status (2)

Country Link
US (1) US4489167A (en:Method)
JP (2) JPS58758A (en:Method)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4962187A (en) * 1984-11-28 1990-10-09 Cota Biotech Common antigen for colorectal and mucinous ovarian tumors and process for isolating the same
GB8618443D0 (en) * 1986-07-29 1986-09-03 Univ London Monoclonal antibodies
US5231009A (en) 1986-08-13 1993-07-27 Molecular Diagnostics, Inc. Cdnas coding for members of the carcinoembryonic antigen family
US5122599A (en) * 1986-08-13 1992-06-16 Molecular Diagnostics, Inc. CDNAS coding for members of the carcinoembryonic antigen family
US6022958A (en) * 1986-08-13 2000-02-08 Bayer Corporation cDNAs coding for members of the carcinoembryonic antigen family
US5204450A (en) * 1988-03-04 1993-04-20 New England Deaconess Hospital Corporation Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
US5241052A (en) * 1988-03-04 1993-08-31 New England Deaconess Hospital Corporation Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
US4914021A (en) * 1988-03-04 1990-04-03 New England Deaconess Hospital Corporation Carcinoma orosomucoid-related antigen, a monoclonal antibody thereto, and their uses
US4921789A (en) * 1988-04-20 1990-05-01 New England Deaconess Hospital Corporation Marker for colorectal carcinoma and methods of detecting the same
US5179008A (en) * 1989-02-09 1993-01-12 Wisconsin Alumni Research Foundation Hybridoma and monoclonal antibody to FHAP
US5001052A (en) * 1989-02-09 1991-03-19 Wisconsin Alumni Research Foundation Immunoassay for FHAP and antibody useful therewith
US5274081A (en) * 1989-09-20 1993-12-28 Immuno A.G. Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
US5576175A (en) * 1989-09-20 1996-11-19 Immuno Aktiengesellschaft Complex suitable for carrying out a method of purifying pre-S hepatitis B surface antigen
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
US5278290A (en) * 1991-05-31 1994-01-11 Applied Biotechnology, Inc. Binding protein for CEA and uses thereof
US5245017A (en) * 1991-05-31 1993-09-14 Applied Biotechnology, Inc. Method for isolating CEA-binding protein
US5281697A (en) * 1991-05-31 1994-01-25 Applied Biotechnology, Inc. CEA-binding protein and uses thereof
US5747268A (en) * 1993-04-22 1998-05-05 Dade International Inc. Tumor marker control
WO1994024569A1 (en) * 1993-04-22 1994-10-27 Baxter Diagnostics Inc. Tumor marker control

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4180499A (en) * 1971-01-27 1979-12-25 Hoffmann-La Roche Inc. Carcinoembryonic antigens
US3960827A (en) * 1972-07-10 1976-06-01 Bjoerklund K B Cancer associated polypeptide antigen, process for its preparation, process for preparing antibodies, process of cancer diagnosis and composition useful as an immunizing agent
US4132769A (en) * 1974-10-30 1979-01-02 Osther Kurt B Cancer antigen, cancer therapy, and cancer diagnosis
US4140753A (en) * 1976-04-30 1979-02-20 Scripps Clinic & Research Foundation Diagnostic method and reagent
SE7609263L (sv) * 1976-08-20 1978-02-21 Wadsworth Charlies Forfaringssett for faststellande av kvantiteten av viss i en biologisk vetska loslig komponent, samt apparat for utovande av forfarandet
US4075194A (en) * 1976-12-09 1978-02-21 Yeda Research And Development Co., Ltd. Novel synthetic undecapeptide and clinical assay
US4178285A (en) * 1978-12-20 1979-12-11 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system

Also Published As

Publication number Publication date
JPS58758A (ja) 1983-01-05
JPH02238000A (ja) 1990-09-20
JPH0244030B2 (en:Method) 1990-10-02
US4489167A (en) 1984-12-18

Similar Documents

Publication Publication Date Title
US4312853A (en) Radioimmunological determination of procollagen (type III) and procollagen peptide (type III)
US4427783A (en) Immunoassay of thymosin α1
JPH0428718B2 (en:Method)
US4353982A (en) Immunochemical assay for creatine kinase-MB isoenzyme
US4737453A (en) Sandwich immunoassay utilizing a separation specific binding substance
US4514505A (en) Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
CA1181685A (en) Method for the identification and purification of human lung tumor-associated antigens (hltaa) and clinical detection and determination of these antigens
US4264571A (en) Radioimmunoassay of thymosin α1
JPH0467914B2 (en:Method)
US4124700A (en) Immunoassay for thymopoietin
EP0103605B1 (en) Method for free ligand assays
CA1265048A (en) Protein which is characteristic of rheumatoid arthritis
US4299814A (en) Radioimmunoassay of MIF
US4746731A (en) Isolated tissue protein PP18
PT90369B (pt) Processo para a preparacao de anticorpos monoclonais para a determinacao imunologica selectiva de peptido do procolagenio intacto (tipo iii) e de procolagenio (tipo iii) em fluidos corporais e processo de determinacao usando esses anticorpos
EP0245052A2 (en) Detection of inflammation and novel antibodies therefor
US4792528A (en) Methods for obtaining monoclonal antibodies useful in enhanced sensitivity immunoassays
US5304498A (en) Method and composition for free ligand assay
Nishida et al. Enzyme immunoassay of pancreatic oncofetal antigen (POA) as a marker of pancreatic cancer.
EP0109078B1 (en) Immunochemical assay of human chorionic gonadotropin and reagent therefor
US4096237A (en) Immunoassay for β-endorphin
EP0158291A2 (en) A method for purifying carcinoembryonic antigen and a method for producing a carcinoembryonic antigen-reactive monoclonal antibody
JPS6212859A (ja) 特定の細菌ポリペプチド及びそれに対する抗体の定量法
CA1075600A (en) Immunoassay for thymopoietin
JPS6231301B2 (en:Method)